在接受美沙维持治疗的男性患者中勃起功能障碍:专注于与焦虑有关的症状
Te-Chang Changchien1,2, Tsung-Jen Hsieh2, Yung-Chieh Yen1,2
1Department of Psychiatry, E-Da Hospital, Kaohsiung City 824, Taiwan.
勃起功能障碍 (ED) 影响了超过一半的甲维持治疗 (MMT) 的男性. 焦虑和酒精使用与ED严重程度有关,而不是MMT持续时间或剂量.
科学领域:
- 临床心理学 临床心理学
- 性健康 性的健康
- 成 药物 药物 药物 药物
背景情况:
- 勃起功能障碍 (ED) 是在接受甲维持治疗 (MMT) 的患者中普遍存在但尚未得到充分研究的问题.
- 了解这个人群中ED的患病率和风险因素对于全面的医疗保健和治疗坚持至关重要.
研究的目的:
- 为了确定男性MMT患者中ED和风险性行为的患病率.
- 确定ED的风险因素,重点关注心理健康状况.
- 为MMT患者提供整体护理策略的信息.
主要方法:
- 一项涉及中国男性MMT患者的横截面研究.
- 收集的人口统计,临床数据和物质使用信息.
- 使用了经过验证的问卷,包括5项勃起功能国际指数,中国健康问卷和台湾抑郁症问卷.
主要成果:
- 在MMT患者中,ED的患病率为55.7%.
- 焦虑和心理症状的得分较高与更严重的ED相关.
- 过去一个月的酒精消费与不太严重的ED有关,这与MMT持续时间或剂量无关.
结论:
- 勃起障碍在MMT患者中很常见,焦虑和酒精使用是重要的因素.
- 医疗保健提供者应在MMT患者中解决ED的心理健康和酒精消费问题.
- 调查结果强调,在MMT计划中需要综合心理健康支持.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
相关概念视频
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Generalized Anxiety Disorder
